Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pro Dex (PDEX) Change in Acquisitions & Divestments (2014 - 2026)

Pro Dex recorded quarterly Change in Acquisitions & Divestments of $1.9 million in Q1 2026, up 190100.0% quarter-over-quarter from $1000.0 in Q4 2022.

Pro Dex's Change in Acquisitions & Divestments history runs 6 years deep, the most recent figure standing at $1.9 million for Q1 2026.

  • In Q1 2026, Change in Acquisitions & Divestments changed N/A year-over-year to $1.9 million; the TTM figure through Mar 2026 stood at $1.9 million (changed N/A YoY), while the FY2025 annual figure was $1.9 million, changed N/A from the prior year.
  • Change in Acquisitions & Divestments came in at $1.9 million for Q1 2026 at Pro Dex, up from $1000.0 in the prior quarter.
  • In the past five years, Change in Acquisitions & Divestments ranged from a high of $1.9 million in Q1 2026 to a low of $1000.0 in Q4 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn
10 Pro Dex 201.21 Mn 193.60 Mn 6.13 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 1.90 Mn
Mar 31, 2026 1.90 Mn
Dec 31, 2022 1,000.00
Dec 31, 2022 1,000.00
Sep 30, 2022 88,000.00
Sep 30, 2022 88,000.00
Jun 30, 2021 1.59 Mn
Jun 30, 2021 1.59 Mn
Mar 31, 2021 2.89 Mn
Mar 31, 2021 2.89 Mn
Sep 30, 2020 115,000.00
Sep 30, 2020 115,000.00
Jun 30, 2020 -508,000.00
Jun 30, 2020 -508,000.00
Mar 31, 2015 1.32 Mn
Mar 31, 2015 1.32 Mn
Dec 31, 2014 318,000.00
Dec 31, 2014 318,000.00